TY - JOUR
T1 - Social Determinants of Cardiovascular Health in African American Children With CKD
T2 - An Analysis of the Chronic Kidney Disease in Children (CKiD) Study
AU - Sgambat, Kristen
AU - Roem, Jennifer
AU - Brady, Tammy M.
AU - Flynn, Joseph T.
AU - Mitsnefes, Mark
AU - Samuels, Joshua A.
AU - Warady, Bradley A.
AU - Furth, Susan L.
AU - Moudgil, Asha
N1 - Funding Information:
Dr Brady receives funding from the US National Institutes of Health/National Heart, Lung, and Blood Institute grants K23-HL-119622, and R56-HL-139620. The other authors declare that they have no relevant financial interests.
Funding Information:
Kristen Sgambat, PhD, Jennifer Roem, MS, Tammy M. Brady, MD, PhD, Joseph T. Flynn, MD, Mark Mitsnefes, MD, Joshua A. Samuels, MD, MPH, Bradley A. Warady, MD, Susan L. Furth, MD, PhD, and Asha Moudgil, MD. Research idea and study design: KS, AM, JR; data analysis/interpretation: JR, KS, AM, TMB, JTF, MM, JAS, SLF, BAW; supervision or mentorship: AM, SLF, BAW. Each author contributed important intellectual content during manuscript drafting or revision, accepts personal accountability for the author's own contributions, and agrees to ensure that questions pertaining to the accuracy or integrity of any portion of the work are appropriately investigated and resolved. The CKiD study was funded by the National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases with additional funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and National Heart, Lung, and Blood Institute grants U01-DK-66143, U01-DK-66174, U01-DK-082194, and U01-DK-66116. None of those funding sources had a role in study design, data collection, analysis, and interpretation of data; writing the report; or decision to submit the report for publication. Dr Brady receives funding from the US National Institutes of Health/National Heart, Lung, and Blood Institute grants K23-HL-119622, and R56-HL-139620. The other authors declare that they have no relevant financial interests. Received May 17, 2020. Evaluated by 2 external peer reviewers and a statistician, with direct editorial input from an International Editor, who served as Acting Editor-in-Chief. Accepted in revised form November 3, 2020. The involvement of an Acting Editor-in-Chief was to comply with AJKD's procedures for potential conflicts of interest for editors, described in the Information for Authors & Journal Policies.
Funding Information:
The CKiD study was funded by the National Institutes of Health / National Institute of Diabetes and Digestive and Kidney Diseases with additional funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and National Heart, Lung, and Blood Institute grants U01-DK-66143 , U01-DK-66174 , U01-DK-082194 , and U01-DK-66116 . None of those funding sources had a role in study design, data collection, analysis, and interpretation of data; writing the report; or decision to submit the report for publication.
Publisher Copyright:
© 2021 National Kidney Foundation, Inc.
PY - 2021/7
Y1 - 2021/7
N2 - Rationale & Objective: To identify differences in socioeconomic factors (SES) and subclinical cardiovascular disease (CVD) markers by race among Chronic Kidney Disease in Children (CKiD) participants and determine whether differences in CVD markers persist after adjusting for SES. Study Design: Analysis of 3,103 visits with repeated measures from 628 children (497 White participants; 131 African American participants) enrolled in the CKiD study. Setting & Participants: Children with mild-moderate CKD with at least 1 cardiovascular (CV) parameter (ambulatory blood pressure, left ventricular mass index [LVMI], or lipid profile) measured. Exposure: African American race. Outcomes: Ambulatory hypertension, LVMI, triglycerides, high-density lipoprotein cholesterol. Analytical Approach: Due to increased CV risks of glomerular disease, the analysis was stratified by CKD cause. Inverse probability weighting was used to adjust for SES (health insurance, household income, maternal education, food insecurity, abnormal birth history). Linear and logistic regression were used to evaluate association of race with CV markers. Results: African American children were disproportionately affected by adverse SES. African Americans with nonglomerular CKD had more instances of ambulatory hypertension and higher LVMI but more favorable lipid profiles. After adjustment for SES, age, and sex, the magnitude of differences in these CV markers was attenuated but remained statistically significant. Only LVMI differed by race in the glomerular CKD group, despite adjustment for SES. Limitations: Study design limits causal inference. Conclusion: African American children with CKD are disproportionately affected by socioeconomic disadvantages compared with White children. The degree to which CV markers differ by race is influenced by disease etiology. African Americans with nonglomerular CKD have increased LVMI, more ambulatory hypertension, and favorable lipid profile, but attenuation in magnitude after adjustment for SES was observed. African Americans with glomerular CKD had increased LVMI, which persisted after SES adjustment. As many social determinants of health were not captured, future research should examine effects of systemic racism on CV health in this population.
AB - Rationale & Objective: To identify differences in socioeconomic factors (SES) and subclinical cardiovascular disease (CVD) markers by race among Chronic Kidney Disease in Children (CKiD) participants and determine whether differences in CVD markers persist after adjusting for SES. Study Design: Analysis of 3,103 visits with repeated measures from 628 children (497 White participants; 131 African American participants) enrolled in the CKiD study. Setting & Participants: Children with mild-moderate CKD with at least 1 cardiovascular (CV) parameter (ambulatory blood pressure, left ventricular mass index [LVMI], or lipid profile) measured. Exposure: African American race. Outcomes: Ambulatory hypertension, LVMI, triglycerides, high-density lipoprotein cholesterol. Analytical Approach: Due to increased CV risks of glomerular disease, the analysis was stratified by CKD cause. Inverse probability weighting was used to adjust for SES (health insurance, household income, maternal education, food insecurity, abnormal birth history). Linear and logistic regression were used to evaluate association of race with CV markers. Results: African American children were disproportionately affected by adverse SES. African Americans with nonglomerular CKD had more instances of ambulatory hypertension and higher LVMI but more favorable lipid profiles. After adjustment for SES, age, and sex, the magnitude of differences in these CV markers was attenuated but remained statistically significant. Only LVMI differed by race in the glomerular CKD group, despite adjustment for SES. Limitations: Study design limits causal inference. Conclusion: African American children with CKD are disproportionately affected by socioeconomic disadvantages compared with White children. The degree to which CV markers differ by race is influenced by disease etiology. African Americans with nonglomerular CKD have increased LVMI, more ambulatory hypertension, and favorable lipid profile, but attenuation in magnitude after adjustment for SES was observed. African Americans with glomerular CKD had increased LVMI, which persisted after SES adjustment. As many social determinants of health were not captured, future research should examine effects of systemic racism on CV health in this population.
KW - African American
KW - cardiovascular disease (CVD)
KW - children
KW - chronic kidney disease (CKD)
KW - dyslipidemia
KW - food insecurity
KW - health inequality
KW - hypertension
KW - left ventricular hypertrophy (LVH)
KW - pediatrics
KW - race
KW - racial differences
KW - social determinants of health
KW - socioeconomic disparities
KW - socioeconomic status (SES)
KW - subclinical CVD
UR - http://www.scopus.com/inward/record.url?scp=85103387201&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85103387201&partnerID=8YFLogxK
U2 - 10.1053/j.ajkd.2020.11.013
DO - 10.1053/j.ajkd.2020.11.013
M3 - Article
C2 - 33418013
AN - SCOPUS:85103387201
SN - 0272-6386
VL - 78
SP - 66
EP - 74
JO - American Journal of Kidney Diseases
JF - American Journal of Kidney Diseases
IS - 1
ER -